Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Actuate Therapeutics, Inc.

NASDAQ: ACTU · Life Sciences · 4 alerts · CIK 1652935

Share price
$0.2680Close, Nov 16
Market cap
$16.2M
Shares outstanding
60.38MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Actuate Therapeutics, Inc. filings on SEC EDGAR ↗

9:36 AM ET Form 4
Insider Buying

Actuate Therapeutics President, CEO and Director Daniel M. Schmitt Buys $50K of Stock

Daniel M. Schmitt, President, CEO and Director, bought 140,844 shares of Actuate Therapeutics, Inc. at $0.355 a share, worth $50K in total on Oct 28, 2026. Shares held after the trade: 442,560 (+46.7%).

Value
$50K
Shares
140,844
Price
$0.3550
Role
President, CEO and Director
Holding change
+46.7%
Trade date
Oct 28, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.